oral semaglutide weight loss dosage chart Semaglutide (Wegovy) for the Treatment

Learn how to safely combine intermittent fasting with GLP-1 receptor agonists

Lilly will be launching small molecule orforglipron in late 2026 following an FDA PDUFA date in April, having built over $1bn in inventory as it anticipates high demand

This investigational drug is distinctive in targeting GIP, GLP-1, and glucagon receptors, a novel approach compared to existing obesity treatments

Learn about food noise, how GLP-1 meds like Wegovy and Zepbound can reduce it, and get tips for managing breakthrough food noise during therapy.

Managing weight loss while taking levothyroxine for thyroid health requires careful coordination